Pharma BD Deal Intelligence

Cephalon, Inc. / Mepha AG

2010 · Acquisition/Merger · $615M · Complete

Announcement Sentiment

Positive

Cephalon agreed to acquire Swiss-based Mepha AG for CHF 622.5M (~$590M announced, $615.4M actual close). Adds emerging-markets branded generics. Closed April 2010.

Did it work? Outcome assessment

Strategic verdict

Partially Achieved

Financial impact

Accretive

Pipeline outcome

Assets Advanced

Assessment window: 5yr post-close.

Key facts

Announced Feb 01, 2010
Closed Apr 09, 2010
Deal value $615M
Deal type Acquisition/Merger
Therapeutic area Multiple therapeutic areas
Indications Multiple therapeutic areas
Key assets Generic and branded pharmaceuticals
Mechanism Branded generics

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals